Manulife (Manufacturers Life Insurance)
RYTM icon

Manulife (Manufacturers Life Insurance)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.35M Buy
57,170
+6,401
+13% +$579K 0.01% 1096
2026
Q1 		$4.42M Sell
50,769
-8,840
-15% -$860K ﹤0.01% 1194
2025
Q4 		$6.37M Sell
59,609
-1,308
-2% -$139K 0.01% 1083
2025
Q3 		$6.15M Sell
60,917
-7,215
-11% -$670K 0.01% 1093
2025
Q2 		$4.31M Buy
68,132
+3,746
+6% +$229K ﹤0.01% 1230
2025
Q1 		$3.41M Buy
64,386
+4,417
+7% +$245K ﹤0.01% 1304
2024
Q4 		$3.36M Buy
59,969
+11,266
+23% +$622K ﹤0.01% 1359
2024
Q3 		$2.55M Sell
48,703
-588
-1% -$28.2K ﹤0.01% 1470
2024
Q2 		$2.02M Buy
49,291
+1,667
+4% +$66.5K ﹤0.01% 1492
2024
Q1 		$2.06M Buy
47,624
+8,386
+21% +$367K ﹤0.01% 1504
2023
Q4 		$1.8M Buy
39,238
+19,075
+95% +$602K ﹤0.01% 1503
2023
Q3 		$462K Sell
20,163
-743
-4% -$16.6K ﹤0.01% 2174
2023
Q2 		$345K Buy
+20,906
New +$377K ﹤0.01% 2266
2022
Q2 		– Sell
-19,385
Closed -$223K – 3123
2022
Q1 		$223K Sell
19,385
-5,310
-22% -$46.6K ﹤0.01% 2698
2021
Q4 		$246K Buy
24,695
+272
+1% +$3.06K ﹤0.01% 2763
2021
Q3 		$319K Sell
24,423
-1,285
-5% -$19.6K ﹤0.01% 2621
2021
Q2 		$503K Buy
25,708
+3,686
+17% +$76.5K ﹤0.01% 2427
2021
Q1 		$468K Buy
22,022
+1,728
+9% +$50.1K ﹤0.01% 2322
2020
Q4 		$603K Buy
20,294
+369
+2% +$9.38K ﹤0.01% 2089
2020
Q3 		$432K Sell
19,925
-437
-2% -$10K ﹤0.01% 2070
2020
Q2 		$444K Buy
20,362
+1,134
+6% +$22.1K ﹤0.01% 2032
2020
Q1 		$293K Buy
19,228
+4,777
+33% +$85.5K ﹤0.01% 2105
2019
Q4 		$332K Sell
14,451
-625
-4% -$13.9K ﹤0.01% 2276
2019
Q3 		$319K Sell
15,076
-30
-0.2% -$644 ﹤0.01% 2285
2019
Q2 		$332K Buy
+15,106
New +$381K ﹤0.01% 2300
2018
Q3 		– Sell
-10,017
Closed -$314K – 3717
2018
Q2 		$314K Buy
10,017
+2,749
+38% +$75.2K ﹤0.01% 2746
2018
Q1 		$145K Buy
7,268
+950
+15% +$25.2K ﹤0.01% 3256
2017
Q4 		$184K Buy
+6,318
New +$167K ﹤0.01% 3069

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RYTM Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Rhythm Pharmaceuticals (RYTM) stake by 13% in Q2 2026, buying an estimated $579K and bringing the position to 57,170 shares worth $6.35M. The position accounts for 0.01% of the portfolio, ranked #1096.

Manulife (Manufacturers Life Insurance) first reported a position in RYTM in Q4 2017 and has held it in 28 quarters since. The position peaked at $6.37M in Q4 2025. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 57,170 shares of Rhythm Pharmaceuticals worth $6.35M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 6,401 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $579K.
  • Rhythm Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1096 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 28 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Rhythm Pharmaceuticals position peaked at $6.37M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.